Who are Normal saline with epinephrine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Low-dose epinephrine, Atropine sulfate and epinephrine, cardiac output changes with "ephedrine", epinephrine perfusion, High-dose epinephrine, IM epinephrine 1:1000.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/normal-saline-with-epinephrine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Normal saline with epinephrine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Normal saline with epinephrine (Normal saline with epinephrine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Sympathomimetic amine / Vasopressor. Area: Emergency Medicine / Critical Care.

marketed Sympathomimetic amine / Vasopressor Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors Emergency Medicine / Critical Care Small molecule Live · refreshed every 30 min

Target snapshot

Normal saline with epinephrine (Normal saline with epinephrine) — West Penn Allegheny Health System. Epinephrine stimulates alpha and beta adrenergic receptors to increase heart rate, blood pressure, and cardiac contractility, while normal saline provides fluid volume and electrolyte balance.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Normal saline with epinephrine TARGET	Normal saline with epinephrine	West Penn Allegheny Health System	marketed	Sympathomimetic amine / Vasopressor	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Low-dose epinephrine	Low-dose epinephrine	Icahn School of Medicine at Mount Sinai	marketed	Sympathomimetic amine / Catecholamine	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Atropine sulfate and epinephrine	Atropine sulfate and epinephrine	Dar El Oyoun Hospital	marketed	Anticholinergic agent and sympathomimetic amine combination	Muscarinic acetylcholine receptors (atropine); alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors (epinephrine)
cardiac output changes with "ephedrine"	cardiac output changes with "ephedrine"	University Tunis El Manar	marketed	Sympathomimetic amine	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
epinephrine perfusion	epinephrine perfusion	Central Hospital, Nancy, France	marketed	Sympathomimetic amine / Catecholamine	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
High-dose epinephrine	High-dose epinephrine	Icahn School of Medicine at Mount Sinai	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
IM epinephrine 1:1000	IM epinephrine 1:1000	University of Louisville	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors

Recent regulatory actions (last 90 days)

2026-03-19 — cardiac output changes with "ephedrine" · FDA · approved · US · University Tunis El Manar

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Sympathomimetic amine / Vasopressor class)

The University of Texas at Arlington · 1 drug in this class
West Penn Allegheny Health System · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Normal saline with epinephrine — Competitive Intelligence Brief. https://druglandscape.com/ci/normal-saline-with-epinephrine. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing